Hussman Strategic Advisors Inc. Takes $3.33 Million Position in CVS Health Corporation $CVS

Hussman Strategic Advisors Inc. acquired a new stake in CVS Health Corporation (NYSE:CVS) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 42,000 shares of the pharmacy operator’s stock, valued at approximately $3,333,000. CVS Health makes up 0.8% of Hussman Strategic Advisors Inc.’s holdings, making the stock its 13th biggest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd increased its position in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares in the last quarter. Corundum Trust Company INC acquired a new stake in shares of CVS Health in the third quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new stake in shares of CVS Health in the fourth quarter worth approximately $29,000. GoalVest Advisory LLC acquired a new stake in shares of CVS Health in the fourth quarter worth approximately $32,000. Finally, SOA Wealth Advisors LLC. boosted its stake in shares of CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 131 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Down 1.4%

Shares of NYSE:CVS opened at $82.12 on Friday. The business has a 50-day moving average price of $76.32 and a 200 day moving average price of $77.97. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $105.24 billion, a price-to-earnings ratio of 59.51, a PEG ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the company earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts expect that CVS Health Corporation will post 7.14 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. The ex-dividend date is Thursday, April 23rd. CVS Health’s payout ratio is currently 192.75%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Leerink Partners reaffirmed an “outperform” rating and issued a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. Sanford C. Bernstein raised CVS Health from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $91.00 to $94.00 in a research note on Thursday, March 12th. Wolfe Research lowered their price target on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, March 2nd. The Goldman Sachs Group lifted their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Finally, Robert W. Baird lifted their price target on CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $95.05.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Regulatory tailwinds for Aetna and clearer PBM policy raised upside visibility for CVS’s Health Services and PBM businesses, boosting investor optimism about Medicare Advantage payments and reduced insulin?pricing uncertainty. Regulatory Tailwinds Article
• Positive Sentiment: Operational efficiency gains from automation: WSJ reports on CVS’s new highly automated distribution center using robots to move millions of items with far fewer staff — a potential long?term margin lever. Robotics/Operations Article
• Positive Sentiment: Competitive positioning: coverage notes CVS is pushing health?services expansion while Walgreens pulls back, which could support share gains in higher?margin care services. Competitive Positioning Article
• Neutral Sentiment: Earnings preview / analyst focus: Wall Street is parsing Q1 metrics (revenue, pharmacy trends and Health Services growth). Investors are waiting for the company’s March?quarter results and management color before re?rating shares. Earnings Countdown Article
• Negative Sentiment: Near?term margin risk: earnings previews caution that benefits segment pressures and elevated costs could weigh on Q1 results, a key reason investors are cautious ahead of the print. Earnings Preview Article
• Negative Sentiment: Market dynamics and valuation: after a strong run-up, the stock’s rich near?term multiples and lighter intraday volume can amplify down?moves as investors lock in gains while awaiting Q1 clarity (contributing to today’s pullback).

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.